关于怀孕的风湿病年鉴2018-2023年:基于观察数据的知识
Kate Duhig1, Kimme L Hyrich2,3
1Maternal and Fetal Health Research Centre, The University of Manchester, Manchester, UK.
Annals of the rheumatic diseases
|February 8, 2024
概括
患有风湿性肌肉骨疾病 (RMDs) 的怀孕带来了独特的挑战. 本综述强调了怀孕期间RMD的研究,重点关注母亲和胎儿的结果,以及药物效应.
科学领域:
- 类风湿病学 类风湿病学
- 产科 产科 产科 产科 产科
- 药理学 药理学是指药理学的学科.
背景情况:
- 患有风湿性肌肉骨疾病 (RMDs) 的女性怀孕引发了对母亲和胎儿健康以及药物安全的担忧.
- 由于干预试验的数量有限,在这个领域产生强有力的证据是很困难的,这使得观察性研究至关重要.
研究的目的:
- 提供2018年1月至2023年12月期间发表的关于怀孕和RMD的研究概述.
- 综合有关怀孕结果,药物暴露影响,胎儿发育和RMD妇女生育能力的研究结果.
主要方法:
- 对观察性研究和已发表的文献进行系统审查.
- 对重点关注怀孕结果,药物安全性和RMD患者生育能力的研究进行分析.
主要成果:
- 观察性研究对于为临床实践和患者关于怀孕前和怀孕护理的决策提供信息至关重要.
- 发表的研究涉及怀孕结果,药物暴露的影响,胎儿健康和RMD妇女的生育能力.
结论:
- 对怀孕和RMD的持续研究对于扩大证据基础至关重要.
- 了解RMD,怀孕和治疗之间的相互作用有助于优化对受影响妇女及其孩子的护理.
相关概念视频
Genome-wide Association Studies-GWAS
12.7K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.7K
The JAK-STAT Signaling Pathway
10.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
10.2K
Rheumatic Heart Disease I: Introduction
1.0K
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
1.0K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
1.3K
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.3K
Rheumatic Heart Disease III: Medical Management
548
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
548
Rheumatic Heart Disease IV: Nursing Management
486
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
486


